UK markets closed
NIKKEI 225
37,552.16 +113.55 (+0.30%) HANG SENG
16,828.93 +317.24 (+1.92%) CRUDE OIL
83.38 +1.48 (+1.81%) GOLD FUTURES
2,337.60 -8.80 (-0.38%) DOW
38,480.66 +240.68 (+0.63%) Bitcoin GBP
53,499.09 +294.34 (+0.55%)
JCR Pharmaceuticals Co., Ltd. (JCRRF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 09:42AM EDT. Market open.
| Previous close | 5.22 |
| Open | 5.22 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 5.22 - 5.22 |
| 52-week range | 5.22 - 10.76 |
| Volume | |
| Avg. volume | 1 |
| Market cap | 654.437M |
| Beta (5Y monthly) | -0.01 |
| PE ratio (TTM) | 18.64 |
| EPS (TTM) | 0.28 |
| Earnings date | N/A |
| Forward dividend & yield | 0.13 (2.53%) |
| Ex-dividend date | 28 Mar 2024 |
| 1y target est | N/A |
Business WireJCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexion
HYOGO, Japan, March 19, 2024--JCR Pharmaceuticals announces achievement of milestone using J-Brain Cargo® for neurodegenerative disease in research collaboration with Alexion.
Business WireJCR Pharmaceuticals Celebrates Rare Disease Day 2024 and Highlights Its Commitment to the Rare Disease Community
HYOGO, Japan, February 29, 2024--JCR Pharmaceuticals celebrates Rare Disease Day 2024 and highlights its commitment to the rare disease community.
Business WireJCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2024 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders
HYOGO, Japan, February 14, 2024--JCR announced the presentation of several datasets demonstrating the potential benefits of its investigational LSD therapies at the WORLDSymposium™.
© 2024 Yahoo. All rights reserved.